关 于 宁 夏 中 科 生 物 科 技 股 份 有 限 公 司 出 资 人 组 会 议 暨 2025 年 第 四 次 临 时 股 东 会 法 律 意 见 书 大成（银）证字[2025]第 G009 号 北 京 大 成 （ 银 川 ） 律 师 事 务 所 www.dentons.cn 银川市金凤区宁安大街 64 号德丰大厦 25 层（750011） 25/F, Defeng Skyscraper, No.64 Ning'an Street, Jinfeng District, 750011, Yinchuan, China Tel: +86 951-5057676 Fax: +86 951-5057863 关于宁夏中科生物科技股份有限公司出资人组会议暨 2025 年第四次临时股东会 关于宁夏中科生物科技股份有限公司 出资人组会议暨 2025 年第四次临时股东会法律意见书 大成（银）证字[2025]第 G009 号 致：宁夏中科生物科技股份有限公司 北京大成（银川）律师事务所受宁夏中科生物科技股份有限公司（以下简称 "公司"）的委托，就公司召开出资人组会议暨2025年第四次临时股东会（以下 简称"本次股东会"）的 ...

宁夏中科生物科技股份有限公司 出资人组会议暨 2025 年第四次临时股东会材料 1 宁夏中科生物科技股份有限公司 出资人组会议暨 2025 年第四次临时股东会议程 现场会议召开时间：2025 年 11 月 7 日上午 9 点 30 分 网络投票时间：采用上海证券交易所网络投票系统，通过交易系统投票平台的投 票时间为 2025 年 11 月 7 日 9:15-9:25，9:30-11:30，13:00-15:00；通过互联网投 票平台的投票时间为会议召开当日的 9:15-15:00。 现场会议地点：公司会议室 现场会议股东会主持人：董事长符杰先生 现场会议出资人组会议主持人：石嘴山市中级人民法院法官 会议表决方式：现场投票与网络投票相结合的方式 股东会会议议程： 一、 宣布会议开幕 二、 宣布参加现场会议的股东（或股东授权代表）人数及其代表的股份总 数，列席会议的董事、高级管理人员、石嘴山市中级人民法院法官、管理人、律 师和其他相关工作人员。 三、 律师确认股东资格合法性 四、 审议表决方法 五、 推选监票人、计票人 六、 审议宁夏中科生物科技股份有限公司重整计划（草案）之出资人权益 调整方案 七、 股东质询和 ...

Core Insights - *ST Ningke (600165.SH) released its Q3 2025 financial report on October 31, 2025, indicating that as of October 30, 2025, there is one institutional investor holding shares in the company [1] Summary by Category Institutional Holdings - A total of 200 million shares of *ST Ningke are held by institutional investors, representing 29.20% of the company's total share capital [1] - The institutional investor identified is Shanghai Zhongneng Enterprise Development (Group) Co., Ltd., which contributes to the overall institutional holding percentage of 29.20% [1]

（三）本次董事会于 2025 年 10 月 30 日上午 10:00 以现场结合通讯方式召 开。 证券代码：600165 股票简称：*ST 宁科 公告编号：临 2025-116 宁夏中科生物科技股份有限公司 第九届董事会第四十七次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 本次董事会应到董事 7 名，实到董事 7 名。 ● 本次董事会共三项议案，经审议全部获得通过。 一、董事会会议召开情况 （一）本次董事会召开符合有关法律、行政法规、部门规章、规范性文件和 《宁夏中科生物科技股份有限公司章程》的规定。 （二）本次董事会通知于 2025 年 10 月 20 日以微信和电子邮件方式送达， 会议材料于 2025 年 10 月 23 日以电子邮件方式送达。 （四）本次董事会应到董事 7 名，实到董事 7 名。 （五）本次董事会由董事长符杰先生主持，全体高级管理人员列席了会议。 二、董事会会议审议情况 与会董事对提交本次会议的三项议案进行了认真审议，表决情况如下： （一）审议《2025 年第三季度报 ...

Group 1 - The core point of the article is that *ST Ningke reported a significant increase in revenue for the third quarter of 2023, but still faced substantial net losses [1] - For the first three quarters of 2023, the company's revenue was approximately 327 million yuan, representing a year-on-year increase of 77.4% [1] - The net loss attributable to shareholders was approximately 251 million yuan, with a basic loss per share of 0.366 yuan [1] Group 2 - As of the report, *ST Ningke's market capitalization was 2.5 billion yuan [2]

Core Viewpoint - *ST Ningke reported a significant increase in revenue for the third quarter, but continued to face substantial net losses [1] Financial Performance - The company's revenue for the third quarter was 112 million, representing a year-on-year growth of 57.34% [1] - For the first three quarters, the total revenue reached 327 million, showing a year-on-year increase of 77.40% [1] - The net loss for the third quarter amounted to 79.98 million [1] - Cumulatively, the net loss for the first three quarters was 251 million [1]

Market Overview - The chemical products sector experienced a decline of 0.57% on the trading day, with Boyuan Co., Ltd. leading the losses [1] - The Shanghai Composite Index closed at 3986.9, down 0.73%, while the Shenzhen Component Index closed at 13532.13, down 1.16% [1] Stock Performance - Notable gainers in the chemical products sector included: - Hangzhou Oxygen Plant Co., Ltd. (002430) with a closing price of 29.52, up 9.99% and a trading volume of 494,700 shares, totaling 1.43 billion yuan [1] - Pioneer New Materials (300163) closed at 4.93, up 6.94% with a trading volume of 1,542,200 shares, totaling 759 million yuan [1] - Jinrongzi (002407) closed at 26.50, up 6.26% with a trading volume of 2,445,100 shares, totaling 6.408 billion yuan [1] - Major decliners included: - Boyuan Co., Ltd. (301617) closed at 94.00, down 7.66% with a trading volume of 78,600 shares, totaling 763 million yuan [2] - Jinhua New Materials (920015) closed at 58.33, down 7.29% with a trading volume of 132,100 shares, totaling 810 million yuan [2] - Poly United (002037) closed at 10.10, down 6.13% with a trading volume of 247,400 shares, totaling 254 million yuan [2] Capital Flow - The chemical products sector saw a net outflow of 933 million yuan from institutional investors, while retail investors contributed a net inflow of 665 million yuan [2] - The capital flow for specific stocks indicated: - Hangzhou Oxygen Plant Co., Ltd. had a net inflow of 1.52 billion yuan from institutional investors, while retail investors had a net outflow of 948.96 million yuan [3] - Yongtai Technology (002326) experienced a net inflow of 1.25 billion yuan from institutional investors, with a net outflow of 2.22 billion yuan from retail investors [3] - Yahua Group (002497) had a net inflow of 1.08 billion yuan from institutional investors, while retail investors saw a net outflow of 657.87 million yuan [3]

Core Viewpoint - The news highlights ongoing legal actions and claims against Ningke Biological and Caesar Culture, with investors seeking compensation due to alleged misconduct and financial discrepancies by these companies [1][2][3][4]. Group 1: Ningke Biological (600165) - Ningke Biological has received a court ruling in favor of investors, allowing them to claim compensation [1]. - The company is undergoing restructuring, with a court decision to accept its reorganization plan, and the deadline for creditors to file claims has been extended to October 31, 2025 [1]. - The proposed repayment plan for ordinary creditors includes cash repayment for amounts up to 150,000 yuan, while amounts exceeding this will be compensated with trust beneficiary rights and additional shares [1]. Group 2: Caesar Culture (002425) - Caesar Culture has been penalized by the Guangdong Securities Regulatory Bureau for financial misconduct, including failing to disclose significant debts and inflating profits by 15.55% in its 2021 annual report [3][4]. - Investors who purchased Caesar Culture shares between April 27, 2022, and May 6, 2024, may also initiate claims for compensation [4]. - The company is currently facing legal scrutiny, with claims being filed against it for alleged false statements and failure to disclose major events [4].

证券代码：600165 股票简称：*ST 宁科 公告编号：临 2025-112 宁夏中科生物科技股份有限公司 关于召开出资人组会议暨 2025 年第四次临时股东会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 宁夏中科生物科技股份有限公司（以下简称：公司）于 2025 年 9 月 17 日 收到宁夏回族自治区石嘴山市中级人民法院送达的（2024）宁 02 破申 2 号《民 事裁定书》及（2025）宁 02 破 2 号《决定书》，裁定受理公司重整，并指定公 司临时管理人担任公司管理人，具体内容详见公司于 2025 年 9 月 18 日披露的 《关于法院受理公司重整并指定管理人的公告》（公告编号：临 2025-100）。 根据《中华人民共和国企业破产法》的相关规定，重整计划草案涉及出资 人权益调整事项的，应当设出资人组对该事项进行表决。因公司重整计划（草 案）涉及出资人权益调整事项，由管理人召集并定于 2025 年 11 月 7 日上午 9 点 30 分在公司会议室召开出资人组会议暨 2025 年第四次临时 ...

宁夏新日恒力国际贸易有限公司 重整计划 （草案） 二〇二五年十月 - 1 - - 3 - | | | | 释义 - | 3 - | | --- | --- | | 前言 - | 8 - | | 摘要 - | 10 - | | 正文 - | 12 - | | 一、恒力国贸的基本情况 - | 12 - | | 二、出资人权益调整方案 - | 16 - | | 三、债权分类、调整和受偿方案 - | 16 - | | 四、剥离资产与信托相关安排 - | 19 - | | 五、经营方案 - | 23 - | | 六、重整计划草案的表决和批准 - | 25 - | | 七、重整计划的执行 - | 27 - | | 八、重整计划的执行监督 - | 28 - | | 九、其他事项 - | 29 - | 释义 在本重整计划草案中，除非文义另有所指，下列左栏中的术 语或简称对应右栏中的含义或全称： 石嘴山中院、法院 指 宁夏回族自治区石嘴山市中级人民法院 《企业破产法》 指 自 2007 年 6 月 1 日起施行的《中华人民共和国企 业破产法》 《破产审判会议纪要》 指 最高人民法院《全国法院破产审判工作会议纪 要》（法〔201 ...